Tag Archives: discussion

AGILE Trial: Frontline Axitinib Versus Sorafenib in mRCC

As part of their Peer Exchange Series, onclive.com presents a discussion of the AGILE Trial by one of the collaborators, Thomas Hutson, and moderated by Daniel J. George from the Duke Cancer Institute in the Clinical Developments in Renal Cell Carcinoma section.

Published online July 22, 2013.

How should we integrate new immunotherapies into treatment strategies for lung cancer?

Drs. Jack West, Mary Pinder, and Nate Pennell review various ways in which emerging immunotherapies could be effectively incorporated into our treatment strategies for lung cancer, potentially adding to or replacing current options.

Published 10th of July 2013 by http://cancerGRACE.org/